Briviact
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Brivaracetam (Briviact): a novel adjunctive therapy for partial-onset seizures.
This final rule adopts without change an interim final rule with request for comments published in the Federal Register on May 12…
The Drug Enforcement Administration is placing the substance brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide…